Statistics for Bacteriophage Phi 6 as surrogate and human-harmless viruses to study anti-SARS-CoV-2 approaches
Total visits
| views | |
|---|---|
| Bacteriophage Phi 6 as surrogate and human-harmless viruses to study anti-SARS-CoV-2 approaches | 441 |
Total visits per month
| views | |
|---|---|
| February 2025 | 19 |
| March 2025 | 1 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
File Visits
| views | |
|---|---|
| Ferraz 2021 COVID.pdf(legacy) | 9 |
| Ferraz 2021 COVID.pdf | 8 |
| PPG_37839.pdf(legacy) | 1 |
| DM_39985.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 255 |
| Germany | 35 |
| Portugal | 34 |
| Canada | 20 |
| China | 13 |
| Belgium | 9 |
| France | 8 |
| United Kingdom | 6 |
| Slovenia | 5 |
| Australia | 4 |
| Sweden | 4 |
| Brazil | 3 |
| India | 3 |
| Italy | 3 |
| South Korea | 3 |
| Poland | 3 |
| Austria | 2 |
| Hong Kong SAR China | 2 |
| Indonesia | 2 |
| Ireland | 2 |
| Iran | 2 |
| Japan | 2 |
| Mongolia | 2 |
| Russia | 2 |
| Singapore | 2 |
| Ukraine | 2 |
| Vietnam | 2 |
| Argentina | 1 |
| Colombia | 1 |
| Spain | 1 |
| Finland | 1 |
| Grenada | 1 |
| Greece | 1 |
| Lithuania | 1 |
| Norway | 1 |
| Thailand | 1 |